Private Equity
Although HNWIs have not been precluded from acquiring positions in pre-IPO businesses via the secondaries market, the process can be complex and fraught with risk.
5 min read · 27 July 2020
The venture capitalist discusses PPP loans, where Lime is experiencing growth and a company that has not survived the downturn.
3 min read · 24 July 2020
In recent years, several venture firms, including CRV, have increased their focus on the bio sector. Here's why we're seeing it grow.
2 min read · 24 July 2020
PwC expects to see an increase in investing across TMT in the coming months as sponsors express more interest in innovation and scalable technology.
3 min read · 24 July 2020
Burgess has long been a target of private equity and strategic buyers, but those opportunities never propelled the entrepreneurial-run payment integrity company to bite.
4 min read · 24 July 2020
Single-asset secondaries deals can allow managers to realise the dream of holding prized assets for longer, but present novel challenges for LPs to evaluate, writes capital raiser Ed Stubbings.
3 min read · 24 July 2020
The global quarantine will become a new benchmark in time – just like the Global Financial Crisis in 2008 – for assessing the resilience of business models, the bankers said.
3 min read · 23 July 2020
Both countries saw their deal metrics start to tick up again in Q2 despite not reaching 2019's numbers and seeing muted funding progress.
2 min read · 23 July 2020
Artemis Capital’s Biodot, a testing solution company, pivots operations to handle the crisis.
3 min read · 23 July 2020
Clearlake is mulling a minority stake sale or 50-50 joint ownership structure for Symplr.
2 min read · 23 July 2020
